StockDiagnosis

BMY Stock Analysis — Bristol-Myers Squibb Company

AI-powered earnings and news diagnosis. Updated regularly.

Company Overview

Sector
HEALTHCARE
P/E Ratio
15.96
EPS
$3.68
Profit Margin
0.15

Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

No public analysis available yet for BMY.

Get a fresh AI diagnosis of BMY

Sign up free — 3 analyses per month included.

Analyze BMY Now